QWINT-3 evaluated the efficacy and safety of once-weekly efsitora compared to once-daily insulin degludec for 78 weeks in adults with type 2 diabetes currently treated with basal insulin.

Tresiba (insulin degludec), a longer-acting insulin, has been shown to be safe and effective in pregnancy, but “there are some concerns in terms of its length of action and its ability to make c ...

while insulin glargine and insulin degludec have side effects that mean some patients are unable to take them. Novo Nordisk has been selling Levemir in the US for nearly 20 years, and in March ...

Ryzodeg ® 70/30 contains two types of insulin: Basal insulin called insulin degludec - this has a long blood sugar level lowering effect. Rapid-acting insulin called insulin aspart - this lowers ...

Ryzodeg ® 70/30 contains two types of insulin: Basal insulin called insulin degludec - this has a long blood sugar lowering effect. Rapid acting insulin called insulin aspart - this lowers your ...

including long-acting insulin degludec, rapid-acting insulin aspart, and premix insulin preparations including the combination of insulin degludec and aspart. To improve the convenience of our ...

The move to list long-acting insulin analogues (insulin degludec, detemir and glargine) and their biosimilars, along with human insulin, is intended to increase access to diabetes treatment by ...